Retraction of: Scientific Reports https://doi.org/10.1038/s41598-019-41760-7, published online 27 March 2019
The Editors have retracted this Article.
After publication, it was brought to the Editors' attention that the S1PR1 ECKO middle panel in Figure 2C appears to partially overlap with S1PR1 ECKO + Vehicle in Figure 3D in1. Further checks by the publisher found additional cases of potential overlap between western blots presented in Figure 1A (S1PR1 Lung VEH and S1PR1 Liver VEH, flipped horizontally), as well as between Figure 4A (p-JNK1/2 lanes 1 and 2) and B (p-JNK1/2 lanes 2 and 1, flipped horizontally).
The Editors requested the original raw data to address these concerns, but the Authors were not able to provide the full data, nor did the data provided contain sufficiently detailed metadata to allow for verification. The Editors therefore no longer have confidence in the reliability of the data presented in this Article.
None of the Authors have responded to correspondence from the Editors about this retraction.
Reference
Zhao, J. et al. Author Correction: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: A potential therapy against pathogenic influenza virus. Sci. Rep. 10, 12946. https://doi.org/10.1038/s41598-020-69835-w (2020).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhao, J., Zhu, M., Jiang, H. et al. Retraction Note: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus. Sci Rep 13, 7592 (2023). https://doi.org/10.1038/s41598-023-34694-8
Published:
DOI: https://doi.org/10.1038/s41598-023-34694-8
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
